Ciprofibrate and triiodothyronine do not suppress in vivo induction of placental glutathione S-transferase expression in rat hepatocytes

Studies on hepatocyte primary cultures have suggested that loss of expression of the placental form of glutathione S-transferase in peroxisome proliferator (PP)-induced hepatocarcinogenesis is due to inhibition of glutathione S-transferase P (GSTP) transcription by the PPs. In the present study, we...

Full description

Saved in:
Bibliographic Details
Published inCancer letters Vol. 151; no. 2; pp. 153 - 159
Main Authors Ledda-Columbano, Giovanna M, Pibiri, Monica, Perra, Andrea, Piga, Rosaria, Loi, Roberto, Dore, Maria, Shinozuka, Hisashi, Columbano, Amedeo
Format Journal Article
LanguageEnglish
Published Shannon Elsevier Ireland Ltd 14.04.2000
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Studies on hepatocyte primary cultures have suggested that loss of expression of the placental form of glutathione S-transferase in peroxisome proliferator (PP)-induced hepatocarcinogenesis is due to inhibition of glutathione S-transferase P (GSTP) transcription by the PPs. In the present study, we have analyzed the effect of a PP, ciprofibrate, and of another ligand of nuclear receptors, 3,3′,5-triiodo- l-thyronine (T3), on GSTP mRNA and protein levels in an in vivo model where GSTP expression was induced in Wistar rats by pre-treatment with a single dose of lead nitrate. Results indicate that administration of ciprofibrate or T3, immediately after lead nitrate treatment, did not exert any inhibitory effect on GSTP mRNA and protein levels, as revealed by both Western and immunohistochemical analysis. The results indicate that PPs do not inhibit hepatocyte GSTP expression induced in vivo by lead nitrate and suggest that inhibition of GSTP expression by PPs may not necessarily be the cause for the rapid disappearance of GSTP-positive preneoplastic lesions observed after a short term exposure to these agents.
ISSN:0304-3835
1872-7980
DOI:10.1016/S0304-3835(99)00407-3